Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01311232
Recruitment Status : Completed
First Posted : March 9, 2011
Last Update Posted : October 27, 2017
Information provided by (Responsible Party):
Won Seog Kim, Samsung Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 1, 2012
  Actual Study Completion Date : December 1, 2013